Posted by Michael Wonder on 28 Mar 2017
AIA NZ shakes up NZ’s insurance market with bolt-on cancer product
28 March 2017 - For the first time in New Zealand, families will be able to access the latest in potentially life-saving cancer treatments through AIA New Zealand, even if their existing health insurance provider excludes them.
In an industry paradigm shift, AIA now allows families to access its high-value immunotherapy cover through AIA’s Cancer Treatment Benefit without changing insurance provider. This will increase consumer choice and provide thousands of Kiwis access to innovative, expensive and potentially life-saving cancer treatments.
Families have previously been denied access to specialist insurance products not offered by existing insurers, such as Southern Cross, because switching health insurance providers in New Zealand can be challenging as pre-existing health conditions may not be covered by a new insurer.
“The insurance market in New Zealand has a history of taking an exclusive approach to policies,” says AIA New Zealand Acting Chief Executive Officer Graeme Edwards. “AIA’s Cancer Treatment Benefit, however, is an example of how an insurance product from one provider can enhance a consumer’s existing policy with another provider.”
